| Identification | Back Directory | [Name]
ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU | [CAS]
113873-67-9 | [Synonyms]
DLDVPIPGRFDRRVSVAAE
[ALA-97]-RII (81-99)
CALCINEURIN SUBSTRATE
2: PN: WO2004056970 TABLE
Calcineurin (PP2B) Substrate
Calcineurin phosphatase substrate
Calcineurin Substrate, ≥97% (HPLC)
CalcineurinSubstrate,CalcineurinSubstrat
Calcineurin (PP2B) Substrate [DLDVPIPGRFDRRVSVAAE], Non-Phosphorylated
CALCINEURIN (PP2B) SUBSTRATE [DLDVPIPGRFDRRVSSVAAE], NON-PHOSPHORYLATED
ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU
H-ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU-OH
ASP-LEU-ASP-VAL-PRO-ILE-PRO-GLY-ARG-PHE-ASP-ARG-ARG-VAL-SER-VAL-ALA-ALA-GLU USP/EP/BP
Calcineurin Substrate trifluoroacetate salt H-Asp-Leu-Asp-Val-Pro-Ile-Pro-Gly-Arg-Phe-Asp-Arg-Arg-Val-Ser-Val-Ala-Ala-Glu-OH trifluoroacetate salt
L-Glutamic acid, L-α-aspartyl-L-leucyl-L-α-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-α-aspartyl-L-arginyl-L-arginyl-L-valyl-L-seryl-L-valyl-L-alanyl-L-alanyl-
L-GlutaMic acid, L-a-aspartyl-L-leucyl-L-a-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-a-aspartyl-L-arginyl-L-arginyl-L-valyl-L-seryl-L-valyl-L-alanyl-L-alanyl-
L-alpha-Aspartyl-L-leucyl-L-alpha-aspartyl-L-valyl-L-prolyl-L-isoleucyl-L-prolylglycyl-L-arginyl-L-phenylalanyl-L-alpha-aspartyl-L-arginyl-L-arginyl-L-valyl-L-seryl-L-valyl-L-alanyl-L-alanyl-L-glutamic acid | [Molecular Formula]
C92H150N28O29 | [MDL Number]
MFCD00236901 | [MOL File]
113873-67-9.mol | [Molecular Weight]
2112.35 |
| Hazard Information | Back Directory | [Uses]
Derived from the RII subunit of cAMP-dependent protein kinase (PKA). Substrate for PKA. Has been used in a non-radioactive assay of calcineurin (protein phosphatase 2B) for screening purposes. | [References]
[1] Guillaume Mabilleau, et al. Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption. Bone. 2016 Oct:91:102-12. DOI:10.1016/j.bone.2016.07.014 |
|
|